MARC보기
LDR01652nmm uu200421 4500
001000000333779
00520240805174525
008181129s2018 |||||||||||||||||c||eng d
020 ▼a 9780438250185
035 ▼a (MiAaPQ)AAI10825116
035 ▼a (MiAaPQ)ucsf:11619
040 ▼a MiAaPQ ▼c MiAaPQ ▼d 248032
0820 ▼a 576
1001 ▼a Levan, Sophia Rose.
24510 ▼a Neonatal Gut-microbiome-derived 12,13 DiHOME Impedes Tolerance and Promotes Childhood Atopy and Asthma.
260 ▼a [S.l.] : ▼b University of California, San Francisco., ▼c 2018
260 1 ▼a Ann Arbor : ▼b ProQuest Dissertations & Theses, ▼c 2018
300 ▼a 66 p.
500 ▼a Source: Dissertation Abstracts International, Volume: 79-12(E), Section: B.
500 ▼a Adviser: Susan V. Lynch.
5021 ▼a Thesis (Ph.D.)--University of California, San Francisco, 2018.
520 ▼a Neonates at risk of childhood atopy and asthma are characterized by gut microbiome perturbation and fecal enrichment of 12,13 DiHOME. However, the underlying mechanism and source of this metabolite in neonates remain poorly understood. Here we s
590 ▼a School code: 0034.
650 4 ▼a Microbiology.
650 4 ▼a Immunology.
650 4 ▼a Health sciences.
690 ▼a 0410
690 ▼a 0982
690 ▼a 0566
71020 ▼a University of California, San Francisco. ▼b Biomedical Sciences.
7730 ▼t Dissertation Abstracts International ▼g 79-12B(E).
773 ▼t Dissertation Abstract International
790 ▼a 0034
791 ▼a Ph.D.
792 ▼a 2018
793 ▼a English
85640 ▼u http://www.riss.kr/pdu/ddodLink.do?id=T14998735 ▼n KERIS
980 ▼a 201812 ▼f 2019
990 ▼a 관리자